Segment Information (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2024 USD ($) segment	Mar. 31, 2023 USD ($)
Segment Reporting [Abstract]
Number of operating segments | segment	2
Segment Reporting Information [Line Items]
Total revenue	$ 156,240	$ 137,220
Total cost of revenue	90,771	82,406
Total gross profit	65,469	54,814
Non-cash stock-based compensation	7,774	4,758
Clinical Services
Segment Reporting Information [Line Items]
Total revenue	134,535	114,869
Total cost of revenue	76,844	67,292
Total gross profit	57,691	47,577
Amortization of acquired intangible assets	4,300	4,300
Non-cash stock-based compensation	300	0
Advanced Diagnostics
Segment Reporting Information [Line Items]
Total revenue	21,705	22,351
Total cost of revenue	13,927	15,114
Total gross profit	7,778	7,237
Amortization of acquired intangible assets	600	600
Non-cash stock-based compensation	$ 100	$ 0